ATLANTA—Two oral drugs, molnupiravir and paxlovid (nirmatrelvir/ritonavir), provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models ...
Using reduction of viral RNA copies as biomarker available across all animal models and human patients, we demonstrate that molnupiravir, but not paxlovid, prevents all SARS-CoV-2 transmission when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results